Home › Funds › BOONE CAPITAL MANAGEMENT LLC › CGEM

BOONE CAPITAL MANAGEMENT LLC position in CGEM

CULLINAN THERAPEUTICS INC · Health Care

BOONE CAPITAL MANAGEMENT LLC reported holding 690,814 shares of CGEM (CULLINAN THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$10.6M, representing 2.81% of its reported portfolio and ranking #14 among its reported holdings. BOONE CAPITAL MANAGEMENT LLC has disclosed CGEM holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)690.81K sh
Reported value held$10.60M
Portfolio Weight2.81%
First reportedQ2 2026
Last changeReduce
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How BOONE CAPITAL MANAGEMENT LLC's CGEM position evolved

BOONE CAPITAL MANAGEMENT LLC first disclosed a stake in CGEM in Q2 2026 at 704,442 shares (US$12.8M). Across 2 filings, BOONE CAPITAL MANAGEMENT LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 690,814 shares valued at US$10.6M — a reduction of -13,628 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q2 2026 704.44K $12.83M New
Q3 2026 690.81K $10.60M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CGEM and 13F data

CGEM (CULLINAN THERAPEUTICS INC) is a Health Care company. 31 other funds we track also report a position in CGEM — the largest reported positions include MPM BioImpact LLC (US$149.2M), Lynx1 Capital Management LP (US$137.6M), BVF INC/IL (US$88.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CGEM

All CGEM fund holders →

FAQ

How long has BOONE CAPITAL MANAGEMENT LLC held CGEM?

BOONE CAPITAL MANAGEMENT LLC has disclosed CGEM holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is BOONE CAPITAL MANAGEMENT LLC's current position in CGEM?

As of Q3 2026, BOONE CAPITAL MANAGEMENT LLC holds 690.81K shares of CGEM (CULLINAN THERAPEUTICS INC), valued at $10.60M, representing 2.81% of its reported portfolio and ranking #14.

Has BOONE CAPITAL MANAGEMENT LLC been buying or selling CGEM?

In the latest 13F filing (Q3 2026), BOONE CAPITAL MANAGEMENT LLC reduced its position in CGEM.

Which other funds hold CGEM?

Other major institutional holders of CGEM include MPM BioImpact LLC, Lynx1 Capital Management LP, BVF INC/IL, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.